RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
T2 Biosystems Stock

T2 Biosystems Liabilities 2024

T2 Biosystems Liabilities

62.83 M USD

Ticker

TTOO

ISIN

US89853L1044

WKN

A119H3

In 2024, T2 Biosystems's total liabilities amounted to 62.83 M USD, a -15.07% difference from the 73.98 M USD total liabilities in the previous year.

T2 Biosystems Aktienanalyse

What does T2 Biosystems do?

T2 Biosystems Inc. is an American company that was founded in 2006. The company is based in Lexington, Massachusetts. The founders of T2 Biosystems aimed to create an innovative diagnostic system that could improve hospital performance. Their business model is based on the development, manufacturing, and distribution of innovative instruments and diagnostic solutions. T2 Biosystems operates in various sectors, with a focus on diagnosis and healthcare solutions. The key areas are: 1. Infectious diseases: T2 Biosystems develops systems that enable rapid and accurate diagnosis of infectious diseases in hospitals and other medical facilities. The team has already made significant progress in detecting infections such as sepsis, pneumonia, and other diseases that require prompt diagnosis to increase patient survival rates. 2. Hematology: The company has also developed a product called T2HemoStat, which improves accuracy in determining biomarkers in blood samples. HemoStat allows for real-time analysis of patient samples to achieve faster results than current standard tests. 3. Healthcare: T2 Biosystems also offers solutions to improve healthcare. The goal is to address issues in healthcare by using data and information more intelligently. The company is working on products tailored to the needs of hospitals and healthcare providers. T2 Biosystems pursues a collaborative strategy, fostering cooperation among clinics, customers, and companies. T2 Biosystems has successfully launched several products, including the T2Dx instrument, which enables rapid and accurate detection of infections. The measurement system is based on T2 Magnetic Resonance (T2MR) technology, which can identify cells and biomolecules based on magnetic resonance. The T2Dx system is also capable of identifying drugs directly in the tests, allowing for better utilization of antibiotics to combat resistant bacteria. In collaboration with Harvard Medical School, the company is also working on developing specific tests focused on the detection of bacteria or viruses. The team at T2 Biosystems has developed an innovative system that allows for the analysis of bacterial or viral strains. T2 Biosystems has a rapidly growing customer base and is a key player in the healthcare market. The company has already established important partnerships with some of the leading hospitals in the US and continues to work on forming further partnerships in other parts of the world. The products of T2 Biosystems have received numerous awards, including the "Best of Show" prize at the Association of Clinical Chemistry Annual Meeting and the "Medical Device Excellence Award" from the Massachusetts Medical Device Industry Council. The company operates in a highly competitive market. To remain competitive, T2 Biosystems heavily invests in research and development. The company also has a strong presence on social media to raise awareness of their products and services. T2 Biosystems aims to achieve further medical advancements and develop innovative technologies to improve patient care in the future. T2 Biosystems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing T2 Biosystems's Liabilities

T2 Biosystems's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating T2 Biosystems's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing T2 Biosystems's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

T2 Biosystems's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in T2 Biosystems’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about T2 Biosystems stock

What is the level of liabilities of T2 Biosystems this year?

T2 Biosystems has a debt balance of 62.83 M USD this year.

What were the liabilities of T2 Biosystems compared to the previous year?

The liabilities of T2 Biosystems have increased by -15.07% dropped compared to the previous year.

What are the consequences of high debt for investors of T2 Biosystems?

High liabilities can pose a risk for investors of T2 Biosystems, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in T2 Biosystems?

Low liabilities mean that T2 Biosystems has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of T2 Biosystems affect the company?

An increase in liabilities of T2 Biosystems can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of T2 Biosystems affect the company?

A decrease in the liabilities of T2 Biosystems can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of T2 Biosystems?

Some factors that can influence the liabilities of T2 Biosystems include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of T2 Biosystems so important for investors?

The liabilities of T2 Biosystems are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can T2 Biosystems take to modify the liabilities?

To change its liabilities, T2 Biosystems can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does T2 Biosystems pay?

Over the past 12 months, T2 Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, T2 Biosystems is expected to pay a dividend of 0 USD.

What is the dividend yield of T2 Biosystems?

The current dividend yield of T2 Biosystems is .

When does T2 Biosystems pay dividends?

T2 Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of T2 Biosystems?

T2 Biosystems paid dividends every year for the past 0 years.

What is the dividend of T2 Biosystems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is T2 Biosystems located?

T2 Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von T2 Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of T2 Biosystems from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did T2 Biosystems pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of T2 Biosystems in the year 2023?

In the year 2023, T2 Biosystems distributed 0 USD as dividends.

In which currency does T2 Biosystems pay out the dividend?

The dividends of T2 Biosystems are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von T2 Biosystems

Our stock analysis for T2 Biosystems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of T2 Biosystems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.